Bausch Health Companies Inc.

Regulatory Filings • Mar 18, 2021

DEFA14A 1 d899103ddefa14a.htm DEFA14A DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☒	Definitive Additional Materials
☐	Soliciting Material Pursuant to § 240.14a-12
BAUSCH HEALTH COMPANIES
INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
☒	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

Your Vote Counts!
BAUSCH HEALTH COMPANIES INC.
	2021 Annual
Meeting Vote by April 23,
2021 11:59 PM
EDT
BAUSCH HEALTH
COMPANIES INC. ATTN: CHRISTINA M.
ACKERMANN 2150 SAINT ELZEAR
BLVD. WEST LAVAL, QUEBEC H7L
4A8 CANADA	●
D37263-P49532

You invested in BAUSCH HEALTH COMPANIES INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To Be Held on April 27, 2021 .

Get informed before you vote

View the Notice of Annual Meeting of Shareholders and Management Proxy Circular, Proxy Statement and Annual Report online at www.ProxyVote.com OR you can receive a free paper or email copy of the material(s) only by requesting prior to April 13, 2021. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. You will need to provide your control number when requesting your copy. If sending an email, please include your control number (indicated below) in the subject line. The materials contain instructions on how to attend and/or vote at the virtual meeting. Unless requested, you will not otherwise receive a paper or email copy.

V1

Vote at www.ProxyVote.com

THIS IS NOT A VOTABLE BALLOT

This is an overview of the proposals being presented at the shareholder meeting. Please follow the instructions on the reverse side to vote these important matters.

Voting Items		Board Recommends
1.	Election of Directors
1a.	Richard U. De Schutter	For
1b.	D. Robert Hale	For
1c.	Brett Icahn	For
1d.	Dr. Argeris (Jerry) N. Karabelas	For
1e.	Sarah B. Kavanagh	For
1f.	Steven D. Miller	For
1g.	Joseph C. Papa	For
1h.	John A. Paulson	For
1i.	Robert N. Power	For
1j.	Russel C. Robertson	For
1k.	Thomas W. Ross, Sr.	For
1l.	Andrew C. von Eschenbach, M.D.	For
1m. Amy B. Wechsler, M.D.		For
2.	The approval, in an advisory vote, of the compensation of our Named Executive Officers.	For
3.	To appoint PricewaterhouseCoopers LLP as the auditor for the Company to hold office until the close of the 2022 Annual Meeting of
Shareholders and to authorize the Company’s Board of Directors to fix the auditor’s remuneration.	For
NOTE: Such other business as may properly come before the meeting or any adjournment or postponement
thereof.

Prefer to receive an email instead? While visiting or voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.

D37264-P49532